Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abbott Laboratories (NYSE:ABT)

43.80
BATS BZX Real-Time Price
As of 1:24pm ET
 +0.23 / +0.53%
Today’s Change
39.28
Today|||52-Week Range
51.74
-2.71%
Year-to-Date

Today’s Trading

Previous close43.57
Today’s open44.31
Day’s range43.62 - 44.44
Volume3,323,224
Average volume (3 months)5,879,206
Market cap$64.9B
Dividend yield2.20%
Data as of 1:09pm ET, 09/02/2015

Growth & Valuation

Earnings growth (last year)-8.61%
Earnings growth (this year)-4.97%
Earnings growth (next 5 years)+9.95%
Revenue growth (last year)-7.33%
P/E ratio27.8
Price/Sales3.40
Price/Book3.05

Competitors

 Today’s
change
Today’s
% change
VRXValeant Pharmaceutic...+5.13+2.29%
AZNAstraZeneca+0.90+2.93%
SHPGShire+5.12+2.31%
LLYEli Lilly and Co+1.36+1.70%
Data as of 1:24pm ET, 09/02/2015

Financials

Next reporting dateOctober 21, 2015
EPS forecast (this quarter)$0.54
Annual revenue (last year)$20.2B
Annual profit (last year)$2.3B
Net profit margin8.50%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
Miles D. White
Chief Financial Officer &
VP-Investor Relations
Brian B. Yoor
Corporate headquarters
Abbott Park, Illinois

Forecasts

Partner Offers